NFE2L2 and Alzheimer disease: While NRF2 expression is elevated in the temporal cortices of AD patients, the activities of antioxidant enzymes, such as glutathione peroxidase and catalase—products of NRF2-target genes—are reduced in the superior temporal gyrus [82,83].